Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: a case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 16150290.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recombinant human-activated protein C (rhAPC) has been suggested to treat sepsis. We present the case of a 19-year-old pregnant patient at the 18th week of gestation with septic shock syndrome that originated from urinary tract infection and was successfully treated with rhAPC.
Medical subject headings
- Fibrinolytic Agents
- Pregnancy Complications, Infectious
- Protein C
- Shock, Septic